ARS Pharmaceuticals, Inc. short interest in 2024
In 2024, ARS Pharmaceuticals, Inc.'s disclosed short interest ran from 7.23% of shares outstanding on 12 Jan 2024 to 14.07% on 31 Dec 2024, a change of +6.84 percentage points. The year's high was 14.25% on 15 Nov 2024 and its low 4.43% on 15 Mar 2024, averaging 9.20% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.80 days on 12 Jan 2024. Full history: ARS Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 7.23% (12 Jan 2024)
- End of year
- 14.07% (31 Dec 2024)
- Change
- +6.84 pp
- High
- 14.25% (15 Nov 2024)
- Low
- 4.43% (15 Mar 2024)
- Average
- 9.20%
- Highest days to cover
- 24.80 (12 Jan 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 7.23% | 24.80 | |
| 31 Jan 2024 | 5.06% | 15.46 | |
| 15 Feb 2024 | 5.07% | 13.87 | |
| 29 Feb 2024 | 4.80% | 4.53 | |
| 15 Mar 2024 | 4.43% | 5.77 | results (8-K) |
| 28 Mar 2024 | 5.70% | 4.59 | 10-K filed, results (8-K) |
| 15 Apr 2024 | 6.31% | 11.05 | |
| 30 Apr 2024 | 6.61% | 13.34 | |
| 15 May 2024 | 7.12% | 15.63 | 10-Q filed, results (8-K) |
| 31 May 2024 | 7.07% | 19.28 | |
| 14 Jun 2024 | 7.10% | 17.12 | |
| 28 Jun 2024 | 7.13% | 6.69 | |
| 15 Jul 2024 | 9.06% | 12.07 | |
| 31 Jul 2024 | 10.29% | 16.89 | |
| 15 Aug 2024 | 12.45% | 7.75 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 11.31% | 7.06 | |
| 13 Sep 2024 | 12.00% | 12.72 | |
| 30 Sep 2024 | 11.45% | 10.37 | |
| 15 Oct 2024 | 12.29% | 15.16 | |
| 31 Oct 2024 | 12.99% | 13.57 | |
| 15 Nov 2024 | 14.25% | 8.60 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 14.02% | 15.29 | |
| 13 Dec 2024 | 13.02% | 12.06 | |
| 31 Dec 2024 | 14.07% | 9.43 |
See also: ARS Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.